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The mitochondrial Uncoupling Protein 2 UCP2 is a member of
the mitochondrial carrier family and belongs to the UCP subfamily.
It is widely expressed in tissues. In immune cells, UCP2 has a
regulatory function through its effect on the production of reactive
oxygen species and MAPK signalling. Ucp2−/− mice are resistant to
infection by parasites and intracellular bacteria but are more
sensitive to chronic inﬂammation and experimental neurodegen-
eration. We found that autoimmune diabetes was strongly
accelerated in Ucp2−/− mice compared to Ucp2+/+ mice with
increased intra-islet lymphocytic inﬁltration. These data highlight
UCP2 as a new player in autoimmune diabetes. In addition, in
agreement with the known inhibitory role of UCP2 on insulin
secretion, loss of function of UCP2 contributes to congenital
hyperinsulinism in patients. The question of whether UCP2 fully
uncouples respiration from ATP synthesis is still debated. Ucp2−/−
cells display enhanced proliferation associated with a metabolic
switch from fatty acid oxidation to glucose metabolism. This
metabolic switch requires the unrestricted availability of glucose,
and Ucp2−/− cells more readily activate autophagy than wild-type
cells when deprived of glucose. Altogether, these results suggest
that UCP2 promotes mitochondrial fatty acid oxidation while
limiting mitochondrial catabolism of pyruvate. UCP2 expression is
also required for efﬁcient oxidation of glutamine in macrophages.
This role of UCP2 in glutamine metabolism appears independent
from its uncoupling activity.
doi:10.1016/j.bbabio.2008.05.028
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At physiological concentrations nitric oxide (NO) inhibits
mitochondrial cytochrome c oxidase in competition with oxygen.
Using a technique based on visible light spectroscopy we have
demonstrated that endogenous NO enhances the reduction of the
electron transport chain, thus enabling cells to maintain their VO2 at
low [O2]. This favours the release of superoxide anion, which
initiates the transcriptional activation of NF-κB as an early stress
signalling response. We have recently used this technique to
demonstrate that NO is inactivated by cytochrome c oxidase in its
oxidised state and that cessation of such inactivation at low [O2]
may account for hypoxic vasodilatation. Many cells respond to a
decrease in oxygen availability via stabilisation of hypoxia-inducible
factor-1α (HIF-1α), whose accumulation is normally prevented by
the action of prolyl hydroxylases. We have found that inhibition of
mitochondrial respiration by low concentrations of NO leads to
inhibition of HIF-1α stabilisation. This prevents the cell from
registering a state of hypoxia at low [O2], which would otherwise
result in upregulation of defensive genes associated with, for
example, glycolysis and angiogenesis. Furthermore, upon inhibition
of mitochondrial respiration in hypoxia, oxygen is redistributed
toward non-respiratory oxygen-dependent targets.
Our results demonstrate that NO acts not only as a physiological
regulator of cell respiration but also as a signalling agent in the
mitochondria and a controller of the distribution of available oxygen.
Such mechanisms may also be involved in the initiation of
pathophysiology.
doi:10.1016/j.bbabio.2008.05.029
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A concept is developed considering aging as an evolution-
facilitating program which is unnecessary and counterproductive
for human and, therefore, should be arrested. To do this, an
attempt is undertaken to inactive mitochondria-produced reactive
oxygen species (ROS) which seem to mediate execution of the
aging program. We synthesized mitochondria-targeted, recharge-
able, hydrophobic antioxidant composed of plastoquinone and
cation of decyltriphenylphosphonium (SkQ1). It is shown that
very low (nmol/kg/day) amounts of SkQ1 increase the lifespan of a
fungus (Podospora anserine), invertebrates (Ceriodaphnia afﬁnis and
Drosophila melanogaster) and a mammal (mouse). Even more
important, in mice SkQ1 abrogates development of such typical
traits of senescence as osteoporosis (kyphosis), decrease in
resistance to infections, depression, alopecia, loss of whiskers,
gray hairs, disappearance of regular oestrous cycles, etc. In rats,
pretreatment with SkQ1 or its homolog, SkQR1, has favourable
effect in the cases of experimental heart arrhythmia, heart and
kidney infarction or stroke. In rats, rabbits, cats, dogs and horses,
drops of 250 nM SkQ1 prevent development of certain types of
cataract, retinopathies and uveitis and in some cases return vision
to animals that became blind due to these pathologies. These data
are consistent with the assumption that SkQ1 interferes with
execution of aging program and is promising in treating some age-
related diseases.
Sponsored by O.V. Deripaska; for review, see Skulachev, V.P.
Biochemistry (Moscow), 2007, 72, 1385-1396; http://protein.bio.msu.
ru/biokhimiya/contents/v72/pdf/bcm_1385.pdf.
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Cytochrome c oxidases, members of the superfamily of heme-
copper containing terminal oxidases, catalyse the reduction of
molecular oxygen to water. Catalytic cycles consist of the oxidized
O-state, the one and two electron reduced E and R-states. The R-
state reacts with oxygen to form the P-state, input of the third
electron leads to the F-state, which is converted to the O-state
again after receiving the fourth electron. The P- (“Peroxy”) and F-
(Ferryl) states are oxoferryl states. Presently the binuclear heme
Fea3–CuB active site is believed to contain either a hydroxyl group
S6 ABSTRACTS / Biochimica et Biophysica Acta 1777 (2008) S2–S111
